INSR and metabolic syndrome: The change in TGs is somewhat reminiscent of the well-described absence of dyslipidemia in patients with monogenic severe insulin resistance due to biallelic or monoallelic INSR mutations, so again this does not preclude the INSR LOF variants being associated with reduced insulin sensitivity.